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Abstract  
Purpose: Diabetes is a leading cause of blindness in the working age population. While 
optometrists have an established role in screening people with known diabetes for eye 
disease, their role in screening for diabetes has not been evaluated. For diabetes screening 
in optometry practices to be successful it must be acceptable to both optometrists and to the 
public. The purpose is to determine acceptability to people attending optometry practices of 
using random capillary blood glucose (rCBG) tests to detect raised blood glucose levels in 
optometry practices 
Methods: A screening service offering people with risk factors or symptoms of diabetes 
rCBG tests was piloted in five high street opticians’ practices in North East England.1002 
people used the screening service during a 20 week period. Each was given a questionnaire 
to complete and return following a rCBG test.  
Results: 939 questionnaires were returned (return rate 93.7%). Mean age of participants 
was 54.5 years; 63.3% were female, 75.0% had not been screened for diabetes previously.  
99.1% agreed or strongly agreed that the location was convenient for them. Only 3.2% 
reported that the test procedure was uncomfortable. 98.0% would recommend others to use 
the screening service. 83.8% of the participants would not have gone elsewhere to have any 
tests done. 148 (15.8%) responded that they would have sought a test elsewhere; 91.5% at 
the GP, 4.7% at a pharmacy and 3.5% elsewhere. 
Conclusions: To those attending opticians’ practices, screening using rCBG tests is 
acceptable in terms of convenience and test comfort, and would recommend the test to 
others. Screening in optometry practices provides an opportunity to identify people at risk of 
diabetes in a hitherto unutilised setting. 
  
3 
 
Introduction 
Worldwide, there are increasing numbers of people with type 2 diabetes1  many of whom are 
unaware they have the disease2-4. In the UK it has been estimated that 22% of diabetes in 
men aged over 50 years remains undiagnosed4.  Identification of these people presents a 
challenge. Screening for undiagnosed disease may help identify some of these missing 
people. Currently much of the screening is carried out in medical settings, often by family 
doctors5. Providing alternative locations as a setting for screening may widen access to 
those at risk who do not routinely access conventional health care settings. 
Optometrists may have an important role to play in the detection and management of 
systemic diseases. Hypertension has been considered as a condition suitable for 
optometrists to screen for and it has been suggested that blood pressure measurement 
could be included as part of a routine eye examination6. Surveys have shown that around 
one tenth of practices have eqipment to measure blood pressure7. It has also been 
suggested that optometrists may have a role to play in screening for depression8 and in 
providing smoking cessation services9. 
Like hypertension, diabetes is a systemic disease which can lead to a variety of ocular 
complications including cataract, nerve palsies and diabetic retinopathy10.While optometrists 
have been involved for many years in screening people with known diabetes for eye 
disease11, and have been shown to be effective and in detecting and managing 
retinopathy12,13. More recently it has been suggested that optometrists can use colour vision 
screening to detect changes in early diabetes14 and may have a role to play in detecting 
diabetic neuropathy by measuring corneal sensitivity15. It is known that diabetes can cause 
both myopic and hyperopic shifts16, and this can allow optometrists to detect previously 
undiagnosed diabetes. However, their role in routine screening for diabetes itself has only 
recently been considered. It has been shown that some optometrists may be willing to carry 
out screening for diabetes providing certain barriers such as cost, training and time can be 
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overcome17. Optometrists are in a position to ask every patient about some diabetic risk 
factors during the course of a sight test. For example, it is known that nearly two-fifth of 
Australian optometrists always ask patients over the age of 40 about diabetes13. Case 
histories taken in the course of an optometric examination should always include questions 
regarding family history of diabetes18.   
To be suitable for screening a disease must be common, have effective treatment or 
management and have a suitable test. Screening using random capillary blood glucose 
(rCBG) or “finger-prick” tests have been used in a number of situations to identify those who 
would benefit from further investigations19-24. rCBG testing has the advantage that it is less 
invasive and time consuming than oral glucose tolerance test, does not require the subject to 
fast and the results are available immediately, so can be carried out in situations where it is 
not possible to get samples to laboratories to be tested.  Currently, in the UK, the Royal 
Pharmaceutical Society of Great Britain has developed guidelines in association with 
Diabetes UK25  for screening using rCBG testing in high street pharmacy practices and this 
service is offered by some high street pharmacists26. 
However, for screening to be successful, it needs to be accessible and acceptable to the 
target population. Ways of making these tests accessible to those at risk need to be 
indentified. Optometrists may have an important role to play in this as they may provide 
services to people who do not access other health care services.   
Aims 
We aimed to ascertain acceptability of using rCBG tests to screen for diabetes and pre-
diabetes in optometrists‟ practices to users of the service.  
Methods 
A screening programme was implemented in five optometry practices (two multiple 
practices, three independents) in North East England. Practices were contacted by letter and 
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those expressing an interest in participating were selected. Screening ran for 4 weeks in 
each practice. Adults attending for sight tests were given a list of risk factors for diabetes 
based on Diabetes UK criteria (A-K in figure 1)27. Those who self reported the presence of 
one or more risk factors were offered a rCBG test. If the optometrist found any ocular finding 
suggestive of diabetes a rCBG was also offered (L in figure 1). 
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Figure 1 Risk factors for inclusion in screening programme  
A. White aged over 40 years or black, Asian and minority ethnic groups aged over 25 with first 
degree family history of diabetes 
B. White aged over 40 years or black, Asian and minority ethnic groups aged over 25 with BMI of 25 
kg/m2 and above 
C. Waist measurement of 94cm ( 37 inches) for white men aged over 40 years and black men aged 
over 25 years and 90cm (35 inches) for Asian men aged over 25, and 80cm (31.5 inches) for white 
women aged over 40 years and black and Asian women aged over 25 years. 
D. People who have ischaemic heart disease, cerebrovascular disease, peripheral vascular disease or 
treated hypertension 
E. People who are known to have impaired glucose tolerance or impaired fasting glycaemia  
F. People with severe mental illness (SMI)  
G. People with raised cholesterol 
H. Women who have had gestational diabetes who have tested normal following delivery  
I. Women who have given birth to a baby weighing more than 4kg (8lb 8oz) 
J. Women with polycystic ovary syndrome  
K. People experiencing symptoms of diabetes (Increased thirst, going to the toilet all the time, 
extreme tiredness, weight loss, genital itching or regular episodes of thrush, slow healing of wounds, 
blurred vision) 
L. Ocular signs/symptoms of diabetes – dot/blot haemorrhages, recurrent infections, variable 
refraction, complaints of visual disturbances, early appearance of cataract. 
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Blood glucose capillary tests were carried out by a healthcare assistant using Bayer 
Contour® meter. This meter uses a sample of capillary whole blood and converts the 
reading to plasma equivalent and gives a result within 5 seconds. Participants with a rCBG 
measurement of ≥6.1mmol/l (whole blood ≥5.6mmol/l ) were advised to see their own GP for 
further investigations in line with Diabetes UK/Royal Pharmaceutical Society of Great Britain 
guidelines25. This cut off point has been calculated to be the most efficient when screening 
for diabetes and prediabetes with sensitivity of 62% and specificity of 70%28.It is also the 
most economic cut off when screening for diabetes28. Full details of the results of the 
screening programme and subsequent follow up has been described elsewhere25, 29. 
Immediately after being given the results of the rCBG test, participants were given a short 
written questionnaire (appendix 1) and asked to complete and return it either by post or to 
the practice. Results were entered and analysed using SPSS 15.0 software. 
Ethics approval was gained from Durham University School of Medicine and Health ethics 
committee. 
Results 
Of the 1303 adults eligible to participate, 1002 adults (77%) were screened. Of these 318 
(31.7%) were subsequently found to have raised rCBG (≥6.1mmol/l) and it was suggested 
that they should visit their GP for further investigations.  
939 questionnaires were returned (response rate 93.7%). There were no significant 
differences between those who returned the questionnaires and those who did not with 
regards to mean age, mean rCBG levels, gender or practice type attended. 
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Table 1 Characteristics of participants in screening and respondents and non-respondents to 
the questionnaire 
 Screening 
(n=1002) 
Questionnaire 
returned 
(n=939) 
Questionnaire 
not returned 
(n=63) 
 
Mean age years 
(SD) 
 
54.40 (16.31) 54.50 (16.36) 53.0 (15.8) T=0.71, p=0.47 
Male (%) 363 (36.2%) 345 (36.7%) 18 (28.6%)  
Female (%) 
 
639 (63.8%) 594 (63.3%) 45 (71.4%)  
White (%) 992 (99.0%) 929 (98.9%) 63 (100%)  
Mixed (%) 3 (0.3%) 3 (0.3%) 0 (0.0%)  
Asian/British 
Asian 
5 (0.5%) 5 (0.5%) 0 (0.0%)  
Black/Black 
British 
1 (0.1%) 1 (0.1%) 0 (0.0%)  
Chinese or other 
 
1 (0.1%) 1 (0.1%) 0 (0.0%)  
Blood glucose  
Mean mmol/l 
(SD) 
 
5.78 (1.34) 
 
5.79 (1.36) 
 
5.51 (1.04) 
 
t=1.6, p=0.11 
<6.1mmol/l 684 (68.3%) 635 (67.6% 49 (77.8%)  
≥6.1mmol/l 
 
318 (31.7%) 304 (32.4%) 14 (22.2%)  
Multiple practice 559 (55.8%) 527 (56.1%) 32 (50.8%)  
Independent 
practice 
443 (44.2%) 412 (43.9%) 31 (49.2%)  
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Participants were asked to rate the convenience, comfort, whether they would recommend 
the test and their expectations of opticians ability to detect health problems using a 5 point 
Likert scale. The responses to the four statements are shown in Table 2. 
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Table 2 – Participants‟ responses 
 Strongly 
agree 
Agree Neither agree 
or disagree 
Disagree Strongly 
disagree 
The opticians practice 
was convenient for 
the screening test 
(n=937) 
82.5% 
(773) 
16.6%  
(156) 
0.6%  
(6) 
0.1%  
(1) 
0.1%  
(1) 
The screening test 
was uncomfortable 
(n=926) 
2.6%  
(24) 
0.6%  
(6) 
1.7%  
(16) 
17.0%  
(157) 
78.1%  
(723) 
I would recommend 
friends/family to have 
the test (n=937) 
82.2%  
(770) 
15.8%  
(148) 
0.6%  
(6) 
0.6%  
(6) 
0.7%  
(7) 
I expect opticians to 
detect health 
problems (n=932) 
56.7%  
(528) 
26.2%  
(244) 
12.6%  
(117) 
3.0%  
(28) 
1.6%  
(15) 
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Only two participants (0.2%) disagreed or strongly disagreed with the idea that the optician‟s 
practice was a convenient location. The majority felt that the location was convenient for 
them. Thirty participants, from the 926 who responded to the statement, reported that the 
test was uncomfortable (24 strongly agreed, 6 agreed). However, only one of these reported 
that they would not recommend the test to family and friends. Over 95% reported that they 
would recommend participation to other people. Comfort of the test and whether they would 
recommend the test to others was not affected by gender or whether a person was referred 
on top their GP as a result of having the rCBG test. Over three quarters of participants 
agreed that opticians should be able to detect health problems. There was no significant 
difference in responses between people attending different practices, between genders or 
for those who screened positive or negative.   
148(16.2%) participants reported that they would have considered going elsewhere for a 
diabetes screening test, while 768 (83.8%) would not. Of the 148 who would have 
considered going somewhere else, 77 (52.0%) had never been tested previously and 69 
(46.6%) reported that they had undergone screening for diabetes prior to participating in the 
study (no details on previous test status for two participants). 
Nearly two-thirds of the population that participated in the screening reported that they had 
never been tested previously and that they would not have gone on to seek out screening 
(n=609). Details of whether a participant reported that they would have considered going 
elsewhere for a screening test shown in table 3. Those who reported that they had been 
screened previously were more likely to actively seek out screening elsewhere, whereas 
gender, practice attended or screening result did not influence this.  
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Table 3 - Responses by gender, previous test, blood glucose levels and practice type 
 Would you go elsewhere   
 No Yes chi-square p 
Male 276 81.4% 63 18.6% 2.34 0.126 
Female 
 
492 85.3% 85 14.7%   
Not tested 
previously 
609 88.8% 77 11.2% 49.01 <0.001* 
Tested 
previously 
 
153 68.9% 69 31.1%   
Blood 
glucose 
<6.1mmol/l 
623 84.6% 95 15.4% 0.86 0.535 
Blood 
glucose 
≥6.1mmol/l 
 
245 82.2% 53 17.8%   
Multiple 
practice 
440 85.4% 75 14.6% 2.207 0.137 
Independent 
practice 
328 81.8% 73 18.2%   
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Of the 148 people who reported that they would have gone elsewhere to request a 
screening test, most (87.8%) reported that they would have been prepared to see their GP 
or practice nurse. 7 (4.7%) would have gone to a pharmacy. 5 (3.4%) said they would have 
gone elsewhere, these included a shopping mall (n=1), self testing with friends or family 
member‟s machine (n=2), hospital (n=1) or with the off-shore medic at work (n=1). Six 
respondents who reported they would go elsewhere did not specify where they would go.  
On the questionnaire space was provided for participants to make any additional comments. 
35% (326) made some comment. These fell in to five broad categories; issues of 
convenience, location, ease and comfort of test, lack of awareness of diabetes and 
screening, and recommendation to others. Examples of participants‟ comments are shown in 
figure 2. 
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Figure 2 – Participants‟ comments 
Convenience 
‘It was good to have the test done without making an appointment at the doctors, especially as I work 
out of town and it was a Saturday’  MI ≥6.1 
‘Very convenient to have test when come to opticians regularly (annually) to have eyes tested, Less 
likely to seek a specific test even if at a pharmacy’ FI <6.1 
„I visit my optician every year. It’s a brilliant idea to have this test at the same time. I had the test done 
while I waited for the optician. It’s a great offer, buy one get one free.‟ FM <6.1 
Location 
 ‘Quick and comfortable, and not stressed out by waiting at a doctors surgery’ FI ≥6.1 
‘Convenient, comfortable atmosphere and friendly staff all helped keep the experience trauma free‟ FI 
≥6.1 
Ease and comfort of test 
‘Pain free and very informative’ FI <6.1 
Lack of awareness of diabetes and screening 
‘Test at optician seem to me to be a good idea. Even though mother had Type 2 diabetes I would not 
have bothered to get tested until symptoms showed. I did not know about slow healing of wounds, it is 
this that encouraged me to take part’ FI ≥6.1  
‘Very convenient and helpful, I would not have booked an appointment with my GP just to see about 
any symptoms unless they were very severe’ FM <6.1 
Recommendation to others 
‘It was completely painless and only took a few minutes. I would therefore recommend everyone to 
have it done’ FM <6.1 
 
Key 
Gender( F=female, M=male)Practice type attended (I=independent, M=Multiple) rCBG result (<6.1, 
≥6.1 
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Discussion 
The relatively high uptake of screening suggested that people attending optometry practice 
are willing to participate in screening, with 77% of those eligible participating. Around one-
third of participants in the screening programme were found to have rCBG requiring further 
investigation which is similar to other studies in Australian pharmacies30. 
Some participants voiced concerns over how painful the test would be prior to taking part, 
and reported a dislike of needles. When the equipment was demonstrated and they could 
see that no needle was visible they were happy to take part. Around 3% reported that the 
test was uncomfortable. Only one of those who reported discomfort would not have 
recommended others to have the screening test done. This may reflect the fact that the 
participants believed that the test was worthwhile even if it did cause some discomfort. 
However, it is also possible that some participants may not have fully read the statements 
and ticked the same agreement level for all four statements. This was true in just over half of 
the thirty cases where they either agreed or strongly agreed that the test was uncomfortable 
(14 strongly agreed with all statements, 3 agreed with all statements). 
The setting of high street optometry practices appears to be convenient for this population. 
This may not be surprising, as people are not tied to a specific practice as they would be 
with a GP, and so can chose a practice that is convenient to them at that particular time. 
Several participants commented that they liked the convenience of being able to have 
different tests done at the same time and location instead of attending two different places. 
The Danish arm of the ADDITION study found that employed people were less likely to 
attend screening than other groups who were not in employment. They suggested that this 
may be due to the fact that, as they did not feel unwell, the employed did not prioritise 
screening over other demands on their time31. If attendance at screening requires an 
individual to take time off work, this may affect their willingness to take up screening. We did 
not investigate the employment status of participants in this study. All the practices that took 
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part in the screening were open six days a week, some with early morning or late night 
opening and one testing seven days a week, in an attempt to provide a service to those who 
were employed and found it difficult to attend in normal office hours. Some participants did 
report that the ability to attend on a Saturday was convenient as they were working and were 
not able to attend during the week.  
The responses showed that offering screening in conjunction with the sight test may result in 
people taking up screening when they would not go out and actively seek it. Nearly two 
thirds of the people who took part reported that they had not been screened previously and 
that they would not have considered going elsewhere to be tested. It had been suggested by 
optometrists that the people most likely to accept the offer of screening in optometry 
practices would be those who would have sought healthcare from other locations32. 
However, from this data we can see that, while some would have been screened before and 
would consider going to the GP or pharmacist for a test, there is a significant number of 
people attending optometry practices who have not considered taking part in any form of 
screening test. Although pharmacies in the UK have been offering screening for several 
years, very few people in this study (4.7% of those who reported that they would somewhere 
else for a test, 0.7% of all respondents) considered going to a pharmacist to request a test.   
In a series of focus groups and interviews with optometrists working in a variety of practice 
types32, concerns were expressed that the public viewed multiple and independent practices 
differently, treating the large multiple chains more like retail outlet, while viewing the smaller 
independent practices as health care providers.  Over three-quarters of people who 
participated in the screening believed that optometrists should be able to detect health 
problems. There was no difference between the proportion of people agreeing or strongly 
agreeing with the statement between those attending multiple practices and independent 
practices. 
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It was also felt that people attending independent practices would be those who would take 
up the offer of screening more willingly, but would also be the people most likely to attend 
elsewhere for screening32. There was a small difference between the proportion of people 
screened previously between the practice types, 22.0% screened previously in those 
attending multiple practices and 28.9% in independent practices. Even though there is a 
statistically significant difference between the two practices type, over 70% of people who 
were screened in either practice type reported that they were not aware of being tested 
previously, which indicates that there is a large population attending both types of practice 
who have risk factors, but have not been screened previously or are not aware that they 
have been tested. Whether people attended a multiple or independent practice had no 
significant effect on whether they would have considered going else where for a screening 
test if they had not been tested as part of the screening study.  
Though the optometrists felt that there were differences between independent and multiple 
practices in terms of how the public viewed them and how those attending the different 
practice types accessed health care32, this was not reflected in the responses to this 
questionnaire to a great extent.  The participants in our study showed little difference in 
responses between those who attended multiples and those attending independents.  
In this screening programme, tests were provided at no cost to participants or the practices. 
Cost is known to be a major barrier in the implementation of a screening programme17. While 
the equipment to carry out the tests is relatively cheap (around £0.63 a test), the time taken 
for the test also needs to be considered and tests funded accordingly. The advantage of 
using rCBG as a screening tool is that the testing procedure is quick, simple and would 
require little training for a practitioner to become proficient.  
Limitations and Strengths 
This survey was only carried out among people who consented to take part in the screening 
procedure, so is self-selecting toward those who are more willing to accept screening. 
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However, only 22% of those eligible chose not to participate indicating a generally good level 
of acceptance among the population attending high street practices. We were unable to 
record details of people who did not wish to participate and why they refused screening tests 
due to ethical considerations so cannot see how they differ from those who did participate. 
However, several people volunteered a reason for non participation. The two most common 
reasons given were that they had been tested recently by their doctor or that they did not 
want to know if they had a problem. Other studies have found between 44%31 and 77%33,34 
attendance after receiving an invitation to attend for rCBG screening. These studies differed 
from this in that the invitation was delivered by post and required the participants to make a 
trip to the test centre to participate. In our study the invitation was made while the person 
was already at the location where the test would take place and a research assistant was on 
hand to answer any questions they may have had.  
Though the sample was biased towards those who would accept screening, by asking the 
participants to complete the questionnaire after the screening test had been carried out and 
the results given we could explore whether a negative or positive screening result affected 
the views of the participant. No significant differences were found in the attitudes of the 
participants who were advised that they should seek out further tests, to those who screened 
negative. 
Conclusions 
Screening for diabetes in optometric practice is acceptable to users and provides 
opportunities for those who may not access other health care providers to participate in 
screening. Potential barriers to screening that have been suggested include acceptance of 
the public and medical professionals, financial and time constraints17. We have shown that 
screening is acceptable to adults attending optometry practices. Further investigations of the 
views of medical professionals and practical implications of implementing a screening 
programme in optometry practices is required. 
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Appendix 1 - Questionnaire 
 Feasibility and acceptability of offering finger-prick blood glucose testing in optometric practice 
Participant ID  ……………..     
Thank you for taking part in the study today. 
We would be very grateful if you could complete following questions as fully as possible.  
The questionnaires are anonymous. The researcher who will look at the responses will not have access to your 
personal details and we will not report individual responses to your optician. 
 
1. How often do you usually visit an optician? Please tick one response 
 ……… Every year 
 ……… Every 2 years 
 ……… Every 3-4 years 
 ……… Less frequently 
 ……… This was my first sight test 
 
2. Have you ever been screened or tested for diabetes before the test that was carried out at the opticians? 
Please tick one response. 
 ……… Yes  
 ……… No 
 
3. Please think about the diabetes test you had done at the opticians (not the sight test) and circle the 
response that you feel most accurately describes your response 
 Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
The opticians practice was convenient 
for the screening test 
1 2 3 4 5 
The screening test was uncomfortable 1 2 3 4 5 
I would recommend friends/family to 
have the test 
1 2 3 4 5 
I expect opticians to be able to detect 
health problems 
1 2 3 4 5 
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4. If you had not had the diabetes test done at the opticians, would you have gone anywhere else and asked 
for a screening test? 
 ……… NO – please go to question 6 
 ……… YES – please go to question 5 
 
5. Where would you have gone for the diabetes test? 
 ……… GP/practice nurse 
 ……… Pharmacy 
 ……… Other  - Please indicate where…………………………………….. 
 
6. If you have any comments about the diabetes screening test you had at the opticians, please write below.  
 
 
 
 
 
 
 
 
Thank you for help. 
 
 
 
Please return the form in the stamped addressed envelope provided. 
 
 
